Diagnosing primary cerebral nocardiosis is difficult. This case report describes a 79-year-old immunocompetent Japanese woman with a primary brain abscess caused by Nocardia otitidiscaviarum (IFM 11321) and reviews the findings of 11 previous patients with N. otitidiscaviarum-induced brain abscesses. Four patients survived, including ours. Beta-lactams were not effective in our patient, and the diagnosis required a pathologic analysis of the surgical specimen. Sulfamethoxazole/trimethoprim (ST) was administered to the patient. On antibiotic susceptibility testing, N. otitidiscaviarum (IFM11321) was found to be resistant to amoxicillin-clavulanic acid, ceftriaxone, cefotaxime, cefepime, imipenem and clarithromycin, but sensitive to amikacin, gentamicin, ST and linezolid. Antimicrobial susceptibility patterns differ among Nocardia species, making species identification important for treatment. Patients with suspected Nocardia infection should therefore be treated empirically with ST and/or amikacin and considered for surgical management.
Introduction
Primary cerebral nocardiosis infrequently occurs in immunocompetent hosts, and diagnosing the disease is difficult in the absence of respiratory and cutis symptoms, requiring the identification of Nocardia species in surgical specimens. In addition, antimicrobial susceptibility patterns differ among Nocardia species, making species identification important for treatment (1) . Nocardia otitidiscaviarum is one of the less commonly isolated species of Nocardia. We herein describe a patient with a brain abscess caused by N. otitidiscaviarum and review the current literature.
Case Report
A 79-year-old Japanese woman without any significant underlying immunodeficiencies was admitted to our hospital. She had a previous history of tuberculosis in her twenties. Her chief complaints were mild left hemiparesis and progressive amnesia beginning five days earlier. On the day of admission, a brain MRI scan revealed a 19.5×15.5×17.0-mm lobulated mass surrounded by significant peripheral edema in the right frontal region (superior frontal gyrus). The abscess exhibited hyperintensity on a T2-weighted MRI scan and rim enhancement following the administration of gadolinium (Fig. 1) .
The patient's body temperature was 37.9 . A neurological examination revealed mild left hemiparesis and amnesia. There were no meningeal signs. An initial blood panel disclosed the following findings: hemoglobin, 13.0 g/dL; hematocrit, 39.3%; white blood cell count, 9,060/μL (neutrophils, 78.7%; lymphocytes, 16.3%); and platelet count, 135×10 3 / μL. Blood chemistry parameters were all within the normal limits, except for a mildly elevated C reactive protein concentration of 0.35 mg/dL. The patient was negative for HIV antibodies, and her serum procalcitonin concentration was <0.05 ng/mL. Assays of the cerebrospinal fluid (CSF) showed a white cell count of 2/μL, a protein concentration of 46 mg/dL and a glucose concentration of 66 mg/dL (blood glucose, 108 mg/dL). She had no respiratory symptoms, and a chest CT scan did not show any signs of respi- ratory infectious disease. Fig. 2 shows the clinical course of the present patient. We started her on treatment with intravenous meropenem (MEPM) at a dose of 6 g/day and glycerin at a dose of 900 mL/day, as well as oral isoniazid (INH) (400 mg/day), rifampicin (RFP) (450 mg/day) and pyrazinamide (PZA) (1,500 mg/day). However, the antituberculosis chemotherapy was halted after PCR showed the patient's CSF and gastric juices to be negative for Mycobacterium tuberculosis. The paralysis of her left limbs rapidly worsened until the limbs became flaccid, and her level of consciousness decreased to that of a semicoma. On the sixth day of hospitalization, the abscess became enlarged and branched (Fig. 3) . The serum toxoplasma IgG antibody concentration was 16 IU/mL, IgM was undetectable and the serum soluble interleukin-2 receptor concentration was 226 U/mL. The level of β-D glucan was <3.9 pg/mL. The CSF and blood were negative for bacterial and fungal cultures, and cryptococcal antigen latex agglutination tests were negative. There were no findings to suggest a Mycobacterium tuberculosis, Toxoplasma, Candida species, Aspergillus or Cryptococcus infection. After treatment with meropenem (6 g/day) for seven days, the patient was treated with panipenem/betamipron (2 g/day) for seven days in addition to sulbactam/ampicillin (3 g/day) plus cefozopran (2 g/day) for 14 days, wating for the timing of surgi- cal intervention. None of these treatments were effective, and we surgically drained the abscess on day 22 of hospitalization in order to identify the causative pathogen(s). A direct microscopic examination of the surgical specimen disclosed branching, beaded, Gram-positive filaments, suggestive of Nocardia species (Fig. 4) . Nocardia species have been described as being weakly acid-fast on Kinyoun staining. N. otitidiscaviarum (IFM 11321) was subsequently identified on a 16S ribosomal RNA gene sequence analysis performed according to a previous study (2) . On day 32 of hospitalization, the patient underwent a second drainage procedure to treat the abscess, and the antibiotic regimen was then changed to oral sulfamethoxazole (1,600 mg/day)/ trimethoprim (320 mg/day) (ST) on day 34.
Clinical and radiological improvements were observed after the second drainage procedure. The patient's level of consciousness and left hemiplegia gradually improved, and her abscess disappeared. We stopped the administration of ST on day 84 and transferred the patient to a rehabilitation facility. She was discharged home on day 265, although she required a walker and continued to suffer from anosognosia and unilateral spatial neglect. As of 18 months, there has been no recurrence of the Nocardia infection.
Discussion
Nocardia species are filamentous, Gram-positive, partially acid-fast, branched bacteria that are ubiquitous in the environment, particularly in the soil. Nocardia can be regarded as primary pathogens, without evidence of underlying illness or immunosuppressive therapy, although they are considered opportunistic pathogens (3) (4) (5) . The Nocardia asteroides group, including N. farcinica and N. nova, are the most common species infecting humans. The most common site of Nocardia infection is the respiratory tract. Nocardia brain abscesses are rare, comprising only 1-2% of all cerebral abscesses (6) . Despite improvements in imaging techniques and surgery, the mortality rate of patients with Nocardia brain abscesses continues to be high (31%) (4).
In humans, N. otitidiscaviarum (formerly N. caviae) causes primary cutaneous, lymphocutaneous and pulmonary infections in both immunocompetent and immunocompromised individuals (7) (8) (9) (10) . Infections caused by N. otitidiscaviarum appear to be rarer than those resulting from other Nocardia species. In Japan, more than 303 strains of pathogenic Nocardia were isolated from patients with nocardiosis from 1992 to 2001 (5). Of these, 219 strains belonged to the N. asteroides group, including N. farcinica (81 strains) and N. nova (33 strains). Fourteen strains were identified as N. otitidiscaviarum and 66 as N. brasiliensis. The annual incidence of N. otitidiscaviarum infections in Japan from 1992 to 2001 was 0-2 strains. Of the 14 patients infected with N. otitidiscaviarum, six had pulmonary infections and six had skin infections; in the remaining two patients, either other organs were involved or such involvement was not identified. No patients exhibited central nervous system involvement. Similarly, of the 347 patients infected with Nocardia in the United States from 1972 to 1974, only 10 (2.9%) were infected with N. otitidiscaviarum and only one (0.3%) displayed central nervous system involvement (3). In addition, of the 113 Nocardia infections in Taiwan from 1998 to 2008, only three (2.7%) were identified as being due to N. otitidiscaviarum (11) , including two patients with pulmonary infections, one with a cutaneous infection and none with central nervous system involvement. Therefore, the frequency of N. otitidiscaviarum-associated brain abscesses is extremely low.
Only 12 cases of N. otitidiscaviarum brain abscesses have been reported to date, including our patient (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . These reports are summarized in Table 1 . The mean and standard deviation of the age at onset was 54.4±20.0 years, and only three patients (25%) were non-immunocompromised. All patients were treated with antibiotics, with six (50%) being treated with ST. Surgical procedures were performed in seven patients (58.3%). Four patients who survived underwent surgical procedures for multiloculated abscesses, with two undergoing two procedures each. Of these 12 patients, eight (66.7%) died despite receiving surgical treatment and/ or antibiotic therapy. The poor prognosis of these patients was due to many factors, including underlying immunodeficiency, delayed diagnosis, a poor general health status and the presence of multiple abscesses. Because all previous reviews were retrospective in nature, the prognosis depended on the timing of diagnosis and the general medical condition of each patient.
Empiric therapy is usually initiated in patients before the results of susceptibility testing are known. The combination of sulfamethoxazole with trimethoprim is used to treat all forms of Nocardia (1, 4, 23, 24) . However, ST-resistant strains of Nocardia, including N. otitidiscaviarum, have been reported in immunocompromised patients (25, 26) . Table 2 shows the antibiotic susceptibility patterns of N. otitidiscaviarum (IFM11321) (27) . N. otitidiscaviarum (IFM 11321) is resistant to amoxicillin-clavulanic acid, ceftriaxone, cefotaxime, cefepime, imipenem and clarithromycin, (1) . Patients suspected to have Nocardia infection should be treated empirically with ST and/or amikacin. The identification of Nocardia species is important due to the species-specific differences in antimicrobial susceptibility patterns.
In our patient, the diagnosis required an examination of the surgical specimen. Two clinical studies conducted to date have suggested that surgical procedures are necessary in most patients with Nocardia brain abscesses (4, 28) . A review of 131 patients with Nocardia brain abscesses reported mortality rates of 24% following craniotomy and excision, 50% after aspiration and drainage and 30% following the administration of non-surgical/antimicrobial therapy (4). Because 22% of these patients were diagnosed at autopsy, care should therefore be taken when interpreting these results.
Surgical management remains controversial. Craniotomy and surgical excision is generally considered necessary for treatment. Aspiration or surgical excision have been recommended for brain abscesses larger than 2.5 cm, abscesses that become enlarged after two weeks of antibiotic treatment and abscesses that fail to shrink after four weeks of antibiotic therapy (4). Burr hole aspiration, a less invasive alternative treatment, has also been reported to be effective. A report of 11 patients with Nocardia brain abscesses found that most were treated with aspiration alone. Notably, no deaths occurred, suggesting that surgical aspiration be considered a suitable initial treatment and repeated if clinically indicated (28) .
In conclusion, abscesses that grow in size and branch off despite timely antibiotic treatment may be caused by Nocardia species. Notably, N. otitidiscaviarum has been found to be resistant to beta-lactams. Patients suspected to have Nocardia infection should be treated empirically with ST and/ or amikacin and considered for surgical management.
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